Structure's aleniglipron elicited over 11% weight loss in a Phase II trial, sending the biotech's stock up nearly 103% as ...

Real-time security clearances are becoming increasingly common in manufacturing of advanced-node semiconductors, where data ...

A Fast Shift Toward Smarter Presales In 2025. Presales move fast this year, and many traders now want early-stage crypto ...

A recent Bloomberg Intelligence study found that buyside European equity traders want lighter regulation, more retail flow ...